<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Varma, Niraj</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Cardiac Implantable Electronic Devices Also Benefit Women, Sometimes More So</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-08-07 11:12:17</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">7-8</style></pages><abstract><style  face="normal" font="default" size="100%">A retrospective “big data” analysis shows that women and men derive a similar survival benefit from both defibrillators and pacemakers. However, women who receive cardiac resynchronization therapy have lower mortality when compared with men. Therefore, strategies must be developed to understand and enhance appropriate utilization of these devices in women.</style></abstract><number><style face="normal" font="default" size="100%">22</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>